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Abstract
The human hCLCA1 and its murine ortholog mCLCA3 (calcium-activated chloride channel regulators) are exclusively
expressed in mucus cells and linked to inflammatory airway diseases with increased mucus production, such as asthma,
cystic fibrosis and chronic obstructive pulmonary disease. Both proteins have a known impact on the mucus cell metaplasia
trait in these diseases. However, growing evidence points towards an additional role in innate immune responses. In the
current study, we analyzed Staphylococcus aureus pneumonia, an established model to study pulmonary innate immunity,
in mCLCA3-deficient and wild-type mice, focusing on the cellular and cytokine-driven innate inflammatory response. We
compared clinical signs, bacterial clearance, leukocyte immigration and cytokine responses in the bronchoalveolar
compartment, as well as pulmonary vascular permeability, histopathology, mucus cell number and mRNA expression levels
of selected genes (mClca1 to 7, Muc5ac, Muc5b, Muc2, Cxcl-1, Cxcl-2, Il-17). Deficiency of mCLCA3 resulted in decreased
neutrophilic infiltration into the bronchoalveolar space during bacterial infection. Only the cytokines IL-17 and the murine
CXCL-8 homolog CXCL-1 were decreased on mRNA and protein levels during bacterial infection in mCLCA3-deficient mice
compared to wild-type controls. However, no differences in clinical outcome, histopathology or mucus cell metaplasia were
observed. We did not find evidence for regulation of any other CLCA homolog that would putatively compensate for the
lack of mCLCA3. In conclusion, mCLCA3 appears to modulate leukocyte response via IL-17 and murine CXCL-8 homologs in
acute Staphylococcus aureus pneumonia which is well in line with the proposed function of hCLCA1 as a signaling molecule
acting on alveolar macrophages.
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Introduction
The human hCLCA1 and its murine ortholog mCLCA3 are
members of the CLCA (calcium-activated chloride channel
regulator) family with a well established role in inflammatory
airway diseases with increased mucus production such as asthma,
cystic fibrosis (CF) and chronic obstructive pulmonary disease
(COPD) [1–4]. The link between CLCA proteins and inflamma-
tory airway diseases has been recognized based on overexpression
of Clca gene products in affected airways which is regulated by
Th2 cytokine signals (IL-4, IL-9, and IL-13) [4,5]. The secreted
proteins hCLCA1 and mCLCA3, which are selectively expressed
in mucus cells of airways and other tissues [6–8] have been directly
linked to the trait of mucus cell metaplasia in inflammatory airway
diseases [9]. Specifically, it was previously demonstrated that
hCLCA1 acts as an extracellular signaling protein, inducing
mucus gene transcription via a downstream mitogen-activated
protein kinase (MAPK)-13 signaling pathway and hereby regulat-
ing mucus cell metaplasia [10]. Hence, hCLCA1 and its ortholog
mCLCA3 have been proposed as biomarkers of inflammatory
airway diseases [11] and as targets for therapeutic intervention in
mucus overproduction [11,12].
However, in addition to the modulation of mucus production
and the strong link to mucus cell metaplasia, CLCA-proteins have
been implicated in the regulation of tissue inflammation in the
innate immune response [13,14]. Indeed, recent studies have
demonstrated that hCLCA1 may act as an innate immune
signaling molecule which activates airway macrophages and
thereby enhances pro-inflammatory cytokine release (IL-8, IL-6,
IL-1b, TNF-a) [15]. Moreover, asthmatic mice treated with anti-
mCLCA3-antibodies showed remarkable reduction of airway
inflammation [16].
So far, only models of chronic and allergic airway inflammation
[9,13,17] and acute inflammation due to LPS [13] have been
characterized in mCLCA3-deficient mice. However, acute bacte-
rial infection appears more suitable to test for a role of mCLCA3
in modulating innate immune responses.
Consequently, this study adopted infection of mCLCA3-
deficient mice with Staphylococcus aureus (S. aureus) which is
one of the most prevalent pathogens of community- and hospital-
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acquired infections in humans accounting for a significant health
and economic burden [18–20]. Besides septicemia, skin and soft
tissue infections, S. aureus causes lower respiratory tract infections
in humans, especially in infants and young children with CF [21–
23].
Here, we hypothesized that mCLCA3 has an impact on the
innate immune response in acute S. aureus infection of the lung.
mCLCA3-deficient mice (mClca32/2) and wild-type (WT) litter-
mates were infected with S. aureus and the course of pneumonia
was analyzed in comparison with uninfected mice regarding
clinical signs, bacterial clearance, leukocyte immigration and
cytokine response in bronchoalveolar lavage fluid (BALF),
pulmonary vascular permeability, histopathology including mor-
phometry, mucus cell quantification and respiratory tract mRNA
expression levels of selected genes of interest, including mClca1 to
7, Muc5ac, Muc5b, Muc2, Cxcl-1, Cxcl-2 and Il-17. We show that
mCLCA3 modulates the cellular leukocyte recruitment via IL-17
and CXCL-1 in bacterial pneumonia and thus appears to have an




All animal procedures were approved by the ethics committee
of the Charite´ - Universita¨t Berlin and local governmental
authorities (Landesamt fu¨r Gesundheit und Soziales Berlin,
approval ID: G 0358/11). The animal studies were conducted
in strict accordance with the FELASA guidelines and recommen-
dations for the care and use of laboratory animals.
Mice
Female mCLCA3-deficient mice (mClca32/2) and C57BL/6J
WT littermates (aged 8–9 weeks and weighing 18–20 g) were
randomly assigned to groups of four and housed in individually
ventilated cages under SPF conditions with a room temperature of
2262uC and a relative humidity of 45%–65%. A 12 hour light/12
hour dark cycle was maintained and the animals had unlimited
access to standard pelleted food and tap water. mClca32/2 mice
were generated on a C57BL/6J background by replacing parts of
exons 7–11 with a neomycin cassette [9]. For all experimental
procedures, excluding the infection procedure, mice were anes-
thetized by intraperitoneal injection of premixed ketamine
(3.2 mg) and xylazine (1.5 mg) and sacrificed by exsanguination
via the caudal Vena cava.
Bacterial Growth and Infection
Staphylococcus aureus Newman (S. aureus) from –80uC glycerol
stocks was plated on Columbia agar with 5% sheep blood and
incubated overnight at 37uC with 5% CO2. Following incubation,
single colonies were picked and incubated in 25 ml Caso-bouillon
(Carl Roth, Karlsruhe, Germany) for 2 to 3 hours at 220 rpm until
midlog phase (A600 = 0.5). After centrifugation at 8006g, the pellet
was resuspended in sterile PBS to an adjusted infectious dose
(56107 cfu S. aureus). For infection, mice were anesthetized by
intraperitoneal injection of premixed ketamine (1.6 mg) and
xylazine (0.5 mg) and transnasally inoculated [24] with 56107
cfu Staphylococcus aureus Newman in 20 ml sterile PBS. Controls
received 20 ml of sterile PBS. Body weight and rectal temperature
(BAT-12 Microprobe, Physitemp, Clifton, NJ, USA) were
recorded every 12 hours.
Bacterial Burden in Lungs, Liver and Blood
Mice were intraperitoneally anesthetized, heparinized, and
blood was taken from the caudal Vena cava. Sterilely dissected
lungs and livers were homogenized, serial dilutions of homoge-
nates and blood were plated on blood agar and incubated (37uC,
5% CO2) for 24 h for subsequent counting of colony forming
units.
Quantification and Differentiation of Leukocytes in BALF
and Blood
At indicated time points, mice were intraperitoneally anesthe-
tized, tracheotomized, ventilated and intracardially heparinized as
described [24]. Blood was taken from the caudal Vena cava and
lungs were perfused with 0.9% NaCl via the pulmonary artery.
Bronchoalveolar lavage was performed twice with 800 ml ice-cold
PBS. After spinning, supernatant was snap frozen for cytokine
analyses. Total leukocytes were counted manually on Neubauer
Chamber and differentiated by fluorescent-activated cell sorter
(FACS) analysis (FACS Calibur, BD Biosciences, Heidelberg
Germany) using forward versus side scatter characteristics and the
specific antibodies CD45 PerCP (clone 30-F11, BD Biosciences),
GR-1 PE (clone RB6-8C5, BD Biosciences) and F4-80 APC (clone
BM8, Invitrogen, Karlsruhe, Germany) as described [25]. Total
blood leukocytes were counted and differentiated by FACS
analysis using BD TruCOUNT Tubes, forward versus side scatter
characteristics and specific antibody staining with CD45 PerCP
and GR-1 PE [25]. Cytospins from BALF were obtained by
centrifugation of 100 ml BALF cell suspension at 206g for
10 minutes (Cytospin 3, Shandon Ltd, Runcorn, UK) and
subsequently stained with May-Gru¨nwald Giemsa.
Pulmonary Vascular Permeability and Protein
Quantification
Mouse albumin (MA) was quantified in BALF and plasma by
ELISA (Biomol, Hamburg, Germany) according to the manufac-
turer’s instructions. Pulmonary vascular permeability was assessed
by calculating the MA BALF/plasma ratio. Total protein of BALF
was measured via bicinchoninacid-assay (BCA) according to the
manufacturer’s instructions using Pierce BCA Protein Assay
(Thermo Scientific, Rockford, USA).











Infiltration by neutrophils 0–4
Infiltration by macrophages 0–4
Lung area affected 0–100%
doi:10.1371/journal.pone.0102606.t001
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Quantification of Cytokines in BALF
Cytokines (IL-1b, IL-6, IL10, IL12p40, IL-13, MCP-1, GM-
CSF, RANTES, CXCL-1 and TNF-a) were measured in the
supernatant of BALF using a cytokine protein multiplex assay
(Bioplex, Bio-Rad, Hercules, CA) and IL-17 was quantified by
ELISA (ab100702, Abcam, Cambridge, UK) according to the
manufacturer’s instructions.
RNA Isolation and Quantitative RT-PCR
Total RNA was isolated from lungs and trachea using Nucleo
Spin RNA/Protein isolation Kit (Macherey Nagel, Du¨ren,
Germany). Total isolated RNA was quality checked and quantified
using the NanoDrop ND-100 Spectrophotometer (Peqlab, Wil-
mington, USA). Transcript expression levels of murine Clca1 to 7,
Muc5ac, Muc5b, Muc2, Il-17, Cxcl-1 and Cxcl-2, normalized to
the reference genes elongationfactor 1a (Ef-1a), b-2 microglobulin
(B2m) and glyceraldehyde-3-phosphate dehydrogenase (Gapdh),
were determined. For exact transversion, 100 ng of RNA from
lungs and trachea were reverse transcribed twice, each time in
20 ml reaction volume using Iscript (BioRad) according to
manufacturer’s instructions. Primers and probes for mClca1,
mClca2, mClca3, mClca5 mClca6, mClca7, Ef1-a [26], Muc5ac,
Muc5b [17], Muc2 [27], Il-17, Gapdh [28] and B2m [29] were
used as described. Primers and probes for mClca4, Cxcl-1 and
Cxcl-2 were designed using Primer3 software (WWW primertool,
Whitehead Institute of Biomedical Research). All primer pairs
encompassed an intron to avoid amplification of genomic DNA. In
silico analysis of primer sequences and probes using NCBI
nucleotide BLAST searches revealed 100% identity only with
the expected DNA sequence. Agarose gel electrophoresis and
sequencing of all PCR-products confirmed an amplification of a
single product of expected size and sequence. For mClca4, no
cross-reactions were detected when linearized, fully cloned cDNA
samples of mClca1 and mClca2 were used as templates. Gapdh,
Ef1-a and B2m were used as internal reference genes. Primer and
probe sequences as well as amplicon sizes and annealing
temperatures are listed in Table S1. An optimized reaction-mix
in a total volume of 15 ml containing Maxima Probe qPCRMaster
Mix (Thermo Scientific, Oxford, USA), forward and reverse
primers (each 0.3 mM), probe (0.2 mM), nuclease free water to
adjusted volume as well as 1 ml of template cDNA was applied and
cycling conditions according to manufacturer’s instructions were
used. RT-qPCR protocols were established using 10 fold serial
dilutions ranging from 102 to 106 copies of purified (Nucleo Spin
Gel and PCR Clean-up, Macherey-Nagel) PCR-derived fragments
of each mRNA. RT-qPCR and data analyses were conducted
using the CFX96 Touch Real-Time PCR Detection System and
CFX Manager software 1.6 (BioRad). Relative quantification and
comparison of groups were performed by the DDCt method using
uninfected wild-type animals as controls.
Western Blot Analysis
BALF proteins were separated by denaturating SDS (10%)
PAGE followed by immunoblotting with mCLCA3 specific
antibodies as described [6].
Histology and Immunohistochemistry
In a separate set of experiments, mice were intraperitoneally
anesthetized, heparinized and blood was taken from the caudal
Vena cava. After careful removal, lungs were immersion-fixed in
4% formalin (pH 7.0) and processed as described [6]. Briefly,
sections were stained with hematoxylin and eosin and periodic
acid-Schiff (PAS) reaction was performed. Three evenly distribut-
ed sections from each lung were scored for various parameters
[30–32] (Table 1), and PAS-positive cells per millimeter of
basement membrane were counted. S. aureus was detected by
immunohistochemistry as described [33].
Figure 1. mCLCA3-deficiency had no impact on clinical
outcome of pneumonia or bacterial loads in lungs. mClca32/2
and WT mice were transnasally infected with 56107 Staphylococcus
aureus Newman or received PBS (controls) and body weights (A) and
temperatures (B) were measured every 6 hours for 24 hours and once
after 48 hours. Values are given as mean 6 SEM (n= 8 each group).
#p,0.05, ##p,0.01, ###p,0.001, ####p,0.0001 versus the PBS
control group. (C) Lung, liver and blood bacterial loads were
determined 6 hours and 24 hours after infection. Values are given as
individual data and mean (n = 11 each group). n.d. = not detected.
doi:10.1371/journal.pone.0102606.g001
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Lung Morphometry for Volume Estimation by the
Cavalieri Principle
Total volume of left lungs from infected mice and corresponding
lesions were assessed by Cavalieri principle [34,35]. Left lungs of
S. aureus infected mice (24 hours post infection, n= 4) were cut
into 140 sections of equal thickness (10 mm). Each seventh section
was stained with hematoxylin and eosin for subsequent determi-
nation of total cut face areas (ACF) as well as total areas of lung
lesions (AL) using digital image analysis software (AnalySIS docu
5.0., SIS). An estimated volume of the left lungs and of left lung
lesions was calculated by multiplying the slab thickness
(T=10 mm67) with the sum of the cut face areas (ACF) or lesion
areas (AL) of each particular section (V=T6g ACF; V=T6gAL)
[34–36]. Finally, the percentages of lesions were calculated.
Figure 2. Chemokine CXCL-1 and cytokine IL-17 were significantly decreased in BALF of infected mCLCA3-deficient mice. (A, B)
Protein levels of cytokines were measured at 12 hours and 24 hours post infection by multiplex assay technique (IL-1b, IL-6, IL-10, IL-12p40, IL-13,
CXCL-1, MCP-1, RANTES, TNF-a, GM-CSF) or by ELISA (IL-17) in BALF. (C) Expression levels of Cxcl-1, Cxcl-2 and Il-17 were quantified by RTq-PCR in the
lungs. Dotted line indicates a fold change of 2 as limit for valid statement of elevated parameters. Values are given as mean 6 SEM (n = 6 to 8 each
group). #p,0.05, ##p,0.01, ###p,0.001, ####p,0.0001 versus PBS control group. *p,0.05 as indicated.
doi:10.1371/journal.pone.0102606.g002
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Data Analysis
Data are expressed as mean 6 SEM. Statistical analyses were
performed using the Mann-Whitney test. P,0.05 was considered
significant.
Results
mCLCA3 deficiency had no impact on clinical outcome of
Staphylococcus aureus pneumonia
After infection of mCLCA3-deficient and wild-type mice with S.
aureus Newman, both genotypes equally developed acute
pneumonia clinically hallmarked by significant loss of body weight
(Figure 1A) and temperature (Figure 1B) compared to PBS
controls. Infected animals showed similarly constant bacterial
loads after 6 and 24 hours which were restricted to the lungs
(Figure 1C). Neither bacteremia nor bacterial spread into the liver
were present at any time investigated confirming a non-bacteremic
S. aureus pneumonia.
mCLCA3 modulated a selective pulmonary inflammatory
cytokine release in acute staphylococcal pneumonia
Inflammatory cytokines were quantified on protein level in
BALF (IL-1b, IL-6, IL-10, IL-12p40, IL-13, IL-17, CXCL-1,
MCP-1, RANTES, TNF-a, GM-CSF) or on mRNA level in lung
homogenates (Cxcl-1, Cxcl-2, Il-17) of S. aureus infected mice and
PBS controls. In infected animals, all cytokine protein levels
analyzed, except for IL-10, were increased 12 hours after infection
as compared to uninfected mice, independently of genotype
(Figure 2A). In contrast, after 24 hours, infected mCLCA3-
deficient mice showed a significant decrease of the cytokines
CXCL-1 and IL-17 compared to infected wild-type mice.
Furthermore, levels of IL-1b, IL-6, IL-13, CXCL-1, TNF-a and
GM-CSF slightly declined, whereas levels of IL-12p40, MCP-1
and RANTES increased over time in infected mice (Figure 2B).
RTq-PCR analysis of lung homogenates after 12 hours showed a
2.17 fold decrease of Cxcl-1-mRNA and a significant 3.4 fold
decrease of Il-17-mRNA in infected mCLCA3-deficient mice
compared to infected wild-type mice. Additionally, Cxcl-2-mRNA
was decreased by a factor of 2.04 in infected mCLCA3-deficient
Figure 3. Pulmonary neutrophils and lymphocytes were significantly decreased in mCLCA3-deficient mice 24 hours after infection.
(A, B) At 12 hours and 24 hours after infection, leukocytes in bronchoalveolar lavage fluid (BALF) were manually counted and subpopulations were
analyzed by fluorescence-activated cell sorter (FACS). Values are given as mean 6 SEM (n= 8 each group). #p,0.05, ##p,0.01, ###p,0.001,
####p,0.0001 versus PBS controls. *p,0.05 as indicated. (C) Cytospins from BALF 24 hours post infection were obtained by centrifugation and
BALF cell suspension was subsequently stained with May-Gru¨nwald Giemsa. Leukocyte numbers were reduced in BALF from mClca32/2 mice (n = 8
each group). Bar, 50 mm.
doi:10.1371/journal.pone.0102606.g003
Figure 4. Early infection with S. aureus led to a comparable increase in systemic leukocyte response. (A, B) At indicated time points after
infection, blood leukocyte numbers and subpopulations were determined by fluorescence-activated cell sorter (FACS). Values are given as mean 6
SEM (n= 8 each group). #p,0.05, ##p,0.01, ###p,0.001 versus the PBS-treated control group.
doi:10.1371/journal.pone.0102606.g004
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mice compared to infected wild-type mice. After 24 hours, Il-17
mRNA levels remained significantly decreased in infected
mCLCA3-deficient mice compared to infected wild-type mice
whereas the mRNA expression of Cxcl-1 and Cxcl-2 of the
infected groups showed similar levels. Moreover, at indicated time
points, mRNA levels of all parameters investigated were signifi-
cantly elevated compared to PBS controls (Figure 2C).
Leukocyte recruitment into Staphylococcus aureus-
infected lungs was dependent on mCLCA3
At indicated time points, leukocyte numbers and subsets were
examined in BALF by fluorescent-activated cell sorter (FACS)
analysis. Total leukocyte numbers increased significantly within 12
hours in infected animals independently of genotype compared to
PBS controls (Figure 3A). Predominantly neutrophils, as well as
macrophages and lymphocytes to a lesser extent, contributed to
the observed leukocyte influx into the bronchoalveolar space
without any genotype difference in numbers. In contrast, 24 hours
after S. aureus infection, mCLCA3-deficient mice showed
significantly decreased numbers of total leukocytes, neutrophils
and lymphocytes compared to infected wild-type mice while
numbers of macrophages remained equal. In uninfected
mCLCA3-deficient mice, leukocyte numbers were comparable to
those of uninfected wild-type mice (Figure 3B). Cytospin analysis
from BALF cell suspensions of infected mice confirmed the results
(Figure 3C). However, only 12 hours after S. aureus infection
systemic leukocyte response in the blood was altered. Numbers of
leukocytes and specifically neutrophils were significantly increased
in infected mice compared to PBS controls, however, indepen-
dently of genotype (Figure 4).
Infected mCLCA3-deficient mice had reduced protein
amounts in BALF without genotype specific changes in
pulmonary vascular permeability
Total protein amount in BALF was determined with the BCA-
method. Infected mice had increased quantities of total protein 12
hours after infection with S. aureus compared to PBS controls
without genotype differences. In contrast, after 24 hours, infected
mCLCA3-deficient mice showed a significant 3-fold reduction of
BALF proteins compared to infected wild-type mice while PBS
controls did not show genotype-specific differences (Figure 5A). As
an indicator for the loss of vascular integrity, mouse albumin (MA)
concentrations were quantified in BALF and plasma. Pulmonary
Figure 5. mCLCA3-deficiency led to reduced protein quantities in BALF during infection without altered pulmonary vascular
permeability. (A) Total protein of BALF was examined at indicated time points by BCA-assay. (B) Mouse albumin (MA) of transnasally infected or
uninfected mice was measured by ELISA in BALF and plasma. Pulmonary vascular permeability was calculated from the MA BALF/plasma ratio. Values
are given as mean 6 SEM (n= 8 each group). #p,0.05, ##p,0.01 versus the PBS control group. *p,0.05 as indicated.
doi:10.1371/journal.pone.0102606.g005
Figure 6. mCLCA3-deficiency in S. aureus infection was not compensated by regulation of other CLCA members. Lung expression
mRNA levels of mClca1 to 7 were quantified by RTq-PCR. Dotted lines indicate a fold change of 0.5 and 2, respectively, as limits for valid statement of
lowered and elevated parameters. Values are given as mean 6 SEM (n = 8 each group). Ct, cycle treshold.
doi:10.1371/journal.pone.0102606.g006
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vascular permeability, assessed by calculating the MA BALF/
plasma ratio, was significantly increased in S. aureus infected mice
compared to PBS controls independently of genotype (Figure 5B).
Staphylococcus aureus infection did not alter mCLCA3
protein and mRNA expression or induce differential
regulation of other CLCA family members in mCLCA3-
deficient mice
Immunoblotting of BALF using mCLCA3-specific antibodies as
well as RTq-PCR analysis of mClca3-mRNA in lungs (Figure 6)
failed to reveal differences on protein or mRNA levels in infected
wild-type mice compared to PBS controls at all time points
investigated. Furthermore, no mCLCA3 mRNA (Figure 6) or
protein was detected in mCLCA3-deficient mice confirming the
knockout status. Additionally, mRNA levels of mClca1 to 7 were
measured in lungs of S. aureus infected mice and PBS controls by
RTq-PCR. mClca1, mClca3, mClca5, and mClca6 were ex-
pressed in the lungs, whereas mClca2, mClca4 and mClca7 were
not detected. After 12 hours, exclusively mClca5 was increased
during infection independently of genotype, therefore no signifi-
cant changes in expression levels of putative compensatory Clca
homologs were observed in the lung (Figure 6).
Mucus cell number and mucin expression were
independent of mCLCA3 during Staphylococcus aureus
infection
Quantification of PAS-positive mucus cells per mm basement
membrane revealed no differences between infected or uninfected
mice independently of genotype at investigated time points
(Figure 7A, 7B). Tracheal mRNA levels of Muc5ac and Muc2
were significantly increased 12 hours after infection in mCLCA3-
deficient mice and wild-type mice compared to PBS controls,
whereas 24 hours after infection only Muc5ac was slightly elevated
in the trachea of infected animals (Figure 7C). In contrast, only
Muc2 was significantly up-regulated on mRNA level in the lungs
of S. aureus infected mice, whereas gene expression levels of the
other mucin genes tested were not differentially regulated in lung
tissue (Figure 7D).
mCLCA3-deficiency had no effect on histological and
morphometric parameters in acute staphylococcal
pneumonia
Course of pneumonia, lung damage and lesion distribution were
further analyzed by pathological investigation. Macroscopical
examination revealed first lesions in infected mice independently
of genotype as early as 6 hours after infection with progressive
exacerbation over time. The upper third of the left lung was
Figure 7. mCLCA3-deficiency had no influence on mucus cell number and mucin expression in infected mice. (A) Mucus cells were
quantified by calculating the percentage of periodic acid Schiff (PAS)-positive cells per mm basement membrane. (B) No differences in number or
distribution of mucus cells were observed in S. aureus infected or uninfected mice. (C, D) Expression levels of Muc5ac, Muc5b and Muc2 were
quantified at indicated time points in trachea and lung by RTq-PCR. Dotted lines indicate fold change of 0.5 and 2, respectively, as limit for valid
statement of lowered and elevated parameters. Values are given as mean 6 SEM (n= 4 each group (A, B), n = 8 each group (C, D)). #p,0.05, ##p,
0.01, ###p,0.001, versus the PBS control group. Bar (B), 20 mm.
doi:10.1371/journal.pone.0102606.g007
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predominantly affected. The altered lung tissue was colored deeply
red and, in few cases, visible accumulations of suppurative
exsudate were present within the pneumonic areas (Figure 8A).
Histologically, infected lungs from both genotypes showed a
moderate to severe, acute, multifocal, necro-suppurative broncho-
pneumonia with prominent perivascular edema, multifocal hem-
orrhage and massive accumulation of neutrophils and macro-
phages in the consolidated areas (Figure 8B). S. aureus was
detected by immunohistochemistry using a specific anti-S. aureus
antibody exclusively in infected animals mostly within macro-
phages and neutrophils at each investigated time point (Figure 8C).
For semiquantification of histologic lesions, total affected lung
Figure 8. No genotype differences in lung inflammation, lesion distribution or bacterial loads were observed during infection. Mice
were transnasally infected with 56107 Staphylococcus aureus Newman and killed at indicated time points. (A) Macroscopic examination revealed
deeply red consolidated areas in the infected lungs (arrowhead) in contrast to PBS controls which behaved virtually identical. (B) Subsequently, lungs
were fixed, embedded in paraffin and stained with hematoxylin and eosin for histopathological analyses. (C) Evidence of bacteria was assessed by
immunohistochemistry with anti-Staphylococcus aureus antibody. Uninfected animals (left panel) served as negative controls. Brown, 3,39-
diaminobenzidine; blue, hematoxylin counterstain. (D) The total lung area affected by inflammation and (E) a lung inflammation score were
determined. Values are given as mean 6 SEM (n= 4 each group). #p,0.05 versus the PBS control group. Bar (B), 100 mm. Bar (C), 20 mm.
doi:10.1371/journal.pone.0102606.g008
Figure 9. mCLCA3 had no impact on severity or expansion of lung inflammation. (A) 24 hours after infection, left lungs of Staphylococcus
aureus infected mice were used for quantification of lung lesions by Cavalieri principle. (B) Percentages of estimated lung lesion volumes and total
lung volumes of the left lungs were calculated. Values are given as mean 6 SEM (n = 4 each group).
doi:10.1371/journal.pone.0102606.g009
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areas were determined (Figure 8D). Additionally, for evaluation of
severity, several parameters were defined (Table 1) and a lung
inflammation score was assessed (Figure 8E). No differences
between genotypes, neither in severity nor in expansion of lung
lesions were observed at indicated time points in S. aureus infected
mice. Only mild infiltration by macrophages close to the hilum of
the lungs was observed in uninfected controls independently of
genotype, likely due to the application of PBS. To examine the
lung as a 3-dimensional structure and to warrant complete
measurement of lung lesions, volume was estimated by Cavalieri
principle in S. aureus infected lungs. Whole left lungs were cut into
consecutive sections of equal thickness and each seventh slide was
analyzed at indicated time points (Figure 9A). No genotype
differences, neither in volume of examined lungs nor in
percentages of lesions were observed (Figure 9B).
Discussion
Several previous studies have analyzed the role of hCLCA1 and
its murine ortholog mCLCA3 which were overexpressed in
complex inflammatory airway diseases, primarily focusing on
mucus cell regulation and induction of mucus cell metaplasia
[9,13,14,17,37–39]. More recently, it has been reported that both
proteins may have an impact on airway inflammation and
regulation of innate immune responses [13–16].
In the present study, we describe an inflammatory phenotype of
mCLCA3-deficient mice in an acute bacterial lung infection
model with Staphylococcus aureus Newman. mCLCA3-deficiency
was associated with decreased protein-levels of CXCL-1 and IL-17
in the BALF compared to wild-type mice 24 hours post infection.
CXCL-1 is a murine homolog to human CXCL-8 and a potent
chemoattractant for neutrophils [40,41] and IL-17 mediates
proinflammatory responses primarily by inducing the expression
of other cytokines and chemokines, including CXCL-8 [42]. In
contrast, all other cytokines tested (IL-1b, IL-6, IL-10, IL-12p40,
IL-13, MCP-1, RANTES, TNF-a and GM-CSF) were signifi-
cantly increased after infection, independently of mCLCA3-
deficiency, pointing towards selective modulation of a specific
subset of cytokines in mCLCA3-deficient mice after bacterial
challenge. Consistent with our protein data, markedly decreased
mRNA-levels of Cxcl-1 and Il-17 were observed as early as 12
hours post infection. Similarly to Cxcl-1, Cxcl-2, another murine
CXCL-8 homolog [43], showed a similar transcriptional regula-
tion in challenged mCLCA3-deficient mice. The reduced induc-
tion of these cytokines on the mRNA and protein levels points
towards aberrant transcriptional regulation in mCLCA3-deficient
mice after S. aureus challenge. As a consequence of the low
CXCL-1 levels, neutrophilic recruitment to the site of infection
was decreased after 24 hours. However, as an alternative
explanation for reduced leukocyte numbers in bronchoalveolar
spaces, capillary-alveolar transmigration may also have been
reduced. Although we failed to observe differences in plasma
protein extravasation, this additional effect cannot be fully
excluded. Besides neutrophils, lymphocytes were also significantly
reduced in the BALF of mCLCA3 deficient mice 24 hours after
infection. The cytokines CXCL-1 and IL-17 found dysregulated in
this study are neither known to be chemoattractants for
lymphocytes nor inducers of lymphocyte proliferation. It is more
likely that a yet unidentified factor influencing lymphocyte
recruitment and/or proliferation may also be modulated after S.
aureus challenge in the context of mCLCA3 deficiency.
We hypothesized that attenuation of coordinated leukocyte
recruitment in mCLCA3-deficient mice was accompanied by
reduced lung barrier destruction. However, the albumin BALF/
plasma ratio, quantified for determination of pulmonary endo-
epithelial barrier failure, was not reduced in mCLCA3-deficient
mice. It thus appears likely that reduction of proteins from viable
and degenerate leukocytes due to decreased bronchoalveolar
leukocyte influx was the main contributor to the diminished total
protein content in BALF of mCLCA3-deficient mice.
The predominant cell types in the lung expressing the two
CXCL-8 homologs CXCL-1 and CXCL-2 during bacterial
infections are alveolar macrophages and pulmonary epithelial
cells [41,44]. Although subsets of T-lymphocytes are the primary
source of IL-17, it was previously demonstrated that alveolar
macrophages are also competent of secreting IL-17 [45,46]. The
altered transcriptional regulation of the CXCL-8-homologs and
IL-17 identified in this study is in line with the recently
hypothesized additional role of CLCA-proteins as signaling
molecules in inflammation [10,15]. Specifically, these studies
demonstrated that hCLCA1, the human ortholog of mCLCA3
with virtually identical structure and cellular expression pattern,
acts as a signaling molecule that induces mucus gene transcription
via a downstream MAPK-13 signaling pathway [10]. Further-
more, hCLCA1 activates alveolar macrophages resulting in pro-
inflammatory cytokine induction, including CXCL-8 [15]. It thus
appears reasonable to assume that mCLCA3 may have a similar
effect on mouse alveolar macrophages after bacterial challenge
with S. aureus via murine CXCL-8 homologs and IL-17.
However, we cannot exclude that the reduced murine CXCL-8
homolog expression in mCLCA3-deficient mice is a downstream
event due to the aberrant induction of IL-17, which is a known
inducer of CXCL-8 [42,47] instead of being directly regulated by
mCLCA3.
A link between IL-17 and mCLCA3 has recently been
suggested. In that study, neutralization of IL-17 in a murine viral
lung infection model decreased mRNA-levels of mClca3 and also
decreased Cxcl-1-mRNA levels with reduced infiltration of
neutrophils into the bronchoalveolar space [48]. Further studies
should elucidate the relation between IL-17 and mCLCA3,
especially the effect of mCLCA3 on IL-17-expressing cell types.
In contrast to our study, a previous study revealed that
mCLCA3-deficient mice challenged with ovalbumin or LPS had
increased numbers of neutrophils and that LPS-treated mice
additionally showed enhanced CXCL-1 protein levels without
alterations in CXCL-2 and IL-17 protein levels [13]. This
seemingly contradictory result may be due to the different
inducers of inflammation (LPS vs. bacterial infection) and/or
different mouse strains used (129SvEvBrd vs. C57BL/6J). More-
over, LPS is an endotoxin from Gram-negative bacteria whereas
in this study we used a Gram-positive bacterial species which could
also account for the seemingly contradictory results.
The acute S. aureus pneumonia in mice is an appropriate
model for studying innate immune responses [18,49–51]. Howev-
er, based on the well established role of CLCA-proteins in Th2
cytokine driven inflammatory airway diseases with increased
mucus production and mucus cell metaplasia [9,13,14,17,37–39],
we also analyzed the effect of mCLCA3 on mucus cells and mucin
gene expression in this acute S. aureus pneumonia. No differences
in the extent of mucus cell metaplasia or mucin gene induction
were observed after infection with S. aureus between mCLCA3-
deficient and wild-type mice. The increase of Muc5ac mRNA
levels without significant changes in Muc5b gene expression in
infected mice compared to PBS controls are consistent with
previous reports [9,10,17]. In addition, Muc2 mRNA levels were
found to be increased in Staphylococcus aureus infected animals
compared to PBS controls independent of genotype corresponding
to previously reported results of lipoteichoic acid (LTA) from gram
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positive bacteria strongly inducing Muc2 expression [52]. The
induction of mucus production under bacterial challenges is thus a
known innate immune response irrespective of the mCLCA3
status.
Interestingly, mCLCA3 independent mucin regulation in
airway diseases shows a discrepancy between mice and humans
[10]. It was previously hypothesized that upregulation of other
members of the murine CLCA family may possibly compensate
for the lack of mCLCA3 [9,10,17]. In addition to mCLCA3, the
murine CLCA5, -6, and -7 are potential candidates to drive mucus
cell metaplasia in mice [11]. Therefore, we analyzed the lungs
regarding a possible compensatory differential regulation of other
murine CLCA homologs. mClca1, mClca3, mClca5, and mClca6
were expressed, whereas mClca2, mClca4 and mClca7 were not
detected. Of these, only mClca5 was increased during infection,
however, independently of genotype. Thus, no differentially
regulated and putatively compensatory CLCA member with
regard to mucus cell regulation was found, even under challenged
conditions which is in line with previous reports [17,53].
In contrast to the observed reduction in neutrophil infiltration,
our pathologic examination failed to reveal differences in lung
inflammation or lung lesion expansion between genotypes despite
using up-to-date morphometric methods [34]. Infected animals
developed an acute, marked, suppurative and necrotizing bron-
chopneumonia with consolidation and destruction of inflamed
areas. Due to this tissue destruction, an exact separation between
lung parenchyma and alveolar spaces was impossible and
histological quantification of cell types in the two separate
compartments that could have confirmed the results of BALF
analyses was impossible. Furthermore, no differences in clinical
course (physical constitution, behavior, body temperature, changes
in body weight) or lung bacterial loads were observed following
infection, indicating that the effect of mCLCA3 on the molecular
and subsequent cellular responses had no obvious impact on
clinical and pathological outcome at the times investigated.
Obviously, additional determinants other than leukocyte number
decide on the overall severity of pneumonia and clinical outcome.
In conclusion, our data suggest that mCLCA3 modulates the
cellular leukocyte recruitment via IL-17 and CXCL-1 in acute S.
aureus pneumonia. Lack of mCLCA3 led to a selectively
decreased induction of IL-17 and CXCL-8 homologs and
decreased numbers of neutrophils and total protein in BALF in
S. aureus infected mice. During bacterial infection, no differences
were observed in mucin regulation and no other mCLCA family
members were differentially regulated. Thus, mCLCA3 seems to
have an impact on the early innate immune response via direct or
indirect induction of select cytokines during S. aureus infection.
Further studies should characterize the specific cytokine
pathways and the main target cells activated by mCLCA3 under
physiological condition and infection. Prospectively, mCLCA3
may even become a potential therapeutic target for the
modulation of inflammation in lung infections.
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